Cardiac resynchronization therapy via left bundle branch pacing vs. optimized biventricular pacing with adaptive
Xueying Chen1, Yang Ye2, Zhongkai Wang3
1Department of Cardiology, Zhongshan Hospital of Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai 200032, China.
Left bundle branch area pacing cardiac resynchronization therapy (LBBP-CRT) offers superior electromechanical resynchronization and improved echocardiographic response compared to biventricular pacing (BVP-aCRT) in heart failure patients with reduced ejection fraction and left bundle branch block.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Management
Background:
- Heart failure with reduced left ventricular ejection fraction (HFrEF) and left bundle branch block (LBBB) presents challenges for cardiac resynchronization therapy (CRT).
- Optimized biventricular pacing (BVP-aCRT) is a standard CRT approach.
- Left bundle branch area pacing (LBBP) is an alternative pacing strategy.
Purpose of the Study:
- To evaluate the feasibility and efficacy of LBBP-CRT compared to BVP-aCRT in patients with HFrEF and LBBB.
- To assess differences in QRS duration, left ventricular ejection fraction (LVEF), and response rates between the two CRT methods.
Main Methods:
- A prospective, non-randomized study enrolled 100 patients with HFrEF and LBBB undergoing CRT.
- Patients were divided into LBBP-CRT (n=49) and BVP-aCRT (n=51) groups.
- Implant characteristics and echocardiographic parameters were assessed at baseline, 6 months, and 1 year.
Main Results:
- LBBP-CRT showed a higher success rate (98.00%) than BVP-aCRT (91.07%).
- LBBP-CRT achieved significantly greater QRS duration reduction, higher absolute LVEF, and improved △LVEF at both 6-month and 1-year follow-ups.
- A higher super-response rate was observed in the LBBP-CRT group at 6 and 12 months.
- Lower pacing thresholds were noted in the LBBP-CRT group throughout follow-up.
Conclusions:
- LBBP-CRT is a feasible and effective alternative to BVP-aCRT for patients with HFrEF and LBBB.
- LBBP-CRT demonstrates superior electromechanical resynchronization, leading to better clinical and echocardiographic outcomes, including a higher super-response rate.
- No significant differences in complications or adverse clinical outcomes were observed between the groups.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Heart Failure Drugs: β-Blockers
Cardiomyopathy II: Dilated Cardiomyopathy


